Profile image
Story Views

Last Hour:
Last 24 Hours:

Biosimilar Market Overview and Comparative Analysis 2016

Monday, November 28, 2016 12:53
% of readers think this story is Fact. Add your two cents.

(Before It's News)

DelveInsight’s, “Biosimilar (Insulin)-Competitive Landscape and Market & Pipeline Analysis, 2016″ discusses the global insulin biosimilar industry. Report analyzes that Insulin and Insulin Biosimilars holds a future scope and potential in the market. It highlights the market trends, regulatory requirements for US and EU and key domestic players. 
Report provides an insight on Insulin Biosimilars that are under development for Type 1 and Type 2 Diabetes with an insight on the Epidemiology of the disease. It provides detailed information on the 11 Insulin Biosimilar that are in pipeline. 
It analyses Insulin Biosimilar industry and discusses the key market trends, major players, market assessment of 6 marketed insulin and the types of insulin with the length activity available in market. Report provides an update on the recent collaborations occurring in the insulin biosimilar market and the companies looking for partnership for the same. 

For more information about this report:

Report Scope:


-Coverage of global insulin biosimilar under development across the globe

-Sales forecast for marketed insulin from 2015 to 2017

-Detailed information on product description and related stage of development, the mode of therapy, mechanism of action, development partner and technology information.

-The report discusses the biosimilar regulatory landscape of various markets including developed markets of the US and EU

-Report analyses the types of insulin under development with respect to their market share and length of activity


Reason to Buy:


-The insulin biosimilar report covers complete Pipeline intelligence and understanding over therapeutics development for insulin market.

-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

-Identify and understand important and diverse types of insulin under development

-Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

-Devise corrective measures for pipeline projects by understanding the insulin biosimilar pipeline in-depth

-Identifying the upcoming leaders in the insulin biosimilar market in the coming year


Request Sample Copy at


Table of contents:
Executive Summary
History of Insulin and Insulin Biosimilar Development
Regulatory Pathways in US and EU
Illustration of the Originator and Biosimilar Development
Major Indication
Complications Associated with Diabetes
Diagnosis of Diabetes
Clinical Trials
Market Assessment
Market Trends
Historical Sales Data for the Marketed Drugs
Forecasted Sales Data for the Marketed Drugs
Major Competitors
Types of insulin and length of activity
Pipeline Therapeutics
Therapeutics under Development by Companies
Therapeutic Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type
Dormant Products
Product Development Activities
Companies involved in Therapeutics Development


Inquire before Buying at


Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.